Anizometrik ambliyopide kapama tedavisinin farklı yaş gruplarındaki etkinliği

Bu çalışmada, anizometropik ambliyopili hastalara uygulanan kapama tedavisinin farklı yaş gruplarına göre etkinliği araştırıldı. Okul öncesi (4-6 yaş grubu) 15 hasta ve okul çağı (7-11 yaş grubu) 19 hasta olmak üzere anizometropik ambliyopi tanısı almış toplam 34 hastaya kapama tedavisi uygulandı. Günlük kapama süresi minimum 6 saat idi. Hastaların başlangıç, 1. ay, 3. ay ve 6. ay' da düzeltilmiş en iyi görme keskinliği ölçülerek, ambliyop gruplar birbirleriyle ve kontrollerle karşılaştırılarak değerlendirildi. Başlangıç görme düzeyleri bakımından, ambliyop okul öncesi ve 7-11 yaş grubu arasında istatistiksel anlamlı fark bulunmazken (P>0.05), ambliyop gruplarla aynı yaş kontroller arasında anlamlı fark vardı (P

The effectiveness of occlusion treatment on anisometric amblyopia in different age groups

The aim of this study was to investigate the efficacy of occlusion treatment on different age group patients with anisometropic amblyopia. Occlusion treatment was applied to 34 patients, 15 preschool children (age between 4-6 years), and 19 school age children (7-11 years). Daily duration of occlusion was minimum 6 hours. Best corrected visual acuity of patients was measured initially, at the end of 1st, 3rd and 6th months. Data belonging to amblyopia groups was compared with one another and with the controls. Initial visual acuity of two amblyopia groups were similar, however there was a significant difference between the amblyopia groups and the controls (P<0.05). Compared to the initial levels, statistically significant recovery was observed in the visual acuity of amblyopia groups measured at the 1st, 3rd and 6th months of treatment (P<0.05). Although no significant difference was found in visual acuity of two amblyopia subgroups 6 months after the completion of treatment, at post-treatment 6th month, amblyopia groups had better visual acuity compared to the controls. In conclusion, occlusion treatment improved the visual acuity in anisometropic amblyopia without a difference between preschool and school age groups.

PDF

___

1. Arden GB and Wooding SL: Pattern ERG in amblyopia. Invest Ophthalmol Vis Sci 1985;26:88-94.
2. Simons K, Reinecke RD.(1978) Amblyopia screening and stereopsis. In: Symposium on Strabismus: Transaction o the New Orleans Acad Ophthalmol, St Louis CV Mosby Co, 15.
3. Townshed AM, Holmes JM, Evans LS. Depth of anisometropic amblyopia and difference in refraction. Am J Ophthalmol 1993;116:431-436.
4. Weınstein WG, Rubin MG. Correction of ametropia with spectacle Lens. Clinical Volum 1. Chapter 35. Duane’s Ophthalmology 1998 CD-ROM Edition.
5. Vital-Durand F, Ayzac L. Tackling amblyopia in human infants. Eye 1996;10:239-243.
6. Noorden GK, Crawford MLJ. The sensitive period. Trans Ophthalmol Soc UK 1979;99:442-6.
7. Sanaç AŞ, Şener C. Şaşılık ve Tedavisi Pelin Ofset ve Matbaacılık San. Ankara 2001; 83-93.
8. Flynn JT, McKenny SG, Dannheim E. Brightness matching in strabismic amblyopia. Am Orthoptic J 1971;21: 38-49.
9. Koç F, Özal H, Kargı Ş, Fırat E. Ambliyopide kapama tedavisi. MN Oftalmoloji 2002;9:161-165.
10. Simmers AJ, Gray LS, McGraw PV, Winn B. Functional visual loss in ambliyopia and effect occlusion therapy. Invest Ophthalmol Vis Sci 1999;40:2859-2871.
11. Von Noorden GK, Leffler MB. Visual acuity in strabismic amblyopia under monocular and binocular conditions. Arch Ophthalmol 1966;76:172-177.
12. Von Noorden GK. Idiopathic ambliyopia. Am J Ophthalmol 1985; 100:214-217.
13. Watson PG, Sanac AS, Pickering MS. A comparison of various methods of treatment of ambliyopia. Trans Ophthalmol Soc UK. 1985;104:319-328.
14. Hiscox F, Strong N, Thompson JR, Minshull C, Woodruff G. Occlusion for ambloypia: a comprehensive survey of outcome. Eye. 1992; 6:300-304.
15. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified? Br J Ophthalmol 2000; 84:572-578.
16. Lithander J, Sjöstrand J. Anisometropic and strabismic amblyopia in the age group 2 years and above: prospective study of the result of treatment. Br J Ophthalmol 1991; 75:111-116.
17. Scott WE, Dickey CF. Stability of visual acuity in amblyopic patients after visual maturity. Arch Clin Exp Ophthalmol 1988; 226:154-157.
18. Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998; 96:431-450.
19. Koç F, Kargı Ş, Özal H, Fırat E. Ambliyopide kapama tedavisinde yaş faktörünün etkisi. T Klin Oftalmoloji 2002, 11:189-194.
20. Epelbaum M, Millevet C, Buisseret P, Pupier JL. The sensitive period for strabismic ambliyopia in humans. Ophthalmol 1993;100:323-326.
21. Eibschitz N, Friedman Z, Newmann E. Comparative result of amblyopia treatment. Metabol Ophthalmol 1978; 2:111-112.
22. Flynn JT, Cassady JC. Current trends in amblyopia therapy. Ophthalmol 1978;84:428-450.
23. Kurt E, Gündüz A, Akçam N, Pekel H. Ambliyopi tedavisinde CAM Vision stimulatörün rolü. T Klinik Oftalmoloji 1997;6:162-164.
24. The Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the Amblyopia Treatment Study. Am J Ophthalmol 2003; 136:620-629.